Hyderabad, March 20 -- Bharat Biotech International Limited (BBIL), a pioneer in affordable indigenous vaccine development and manufacturing, announced today the launch of India's only vertically integrated, purpose-designed Cell and Gene Therapy (CGT) Infrastructure and Viral Vector Production Facility at Genome Valley in Telangana's Hyderabad expanding its expertise from vaccine innovation to leading-edge regenerative and personalised therapies that promise hope for millions, said a release.

As per the release, this facility ushers in a new era of gene and cell therapies to tackle scientific challenges such as targeted gene expression, immune system modulation, and long-term cell survival. The work will span from boosting immune respon...